Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000937
Chunk: 7

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 7
---
000,000) of the Company’s American Depositary Shares (the “”), each representing 10,000 of the Company’s ordinary shares, nominal value £0.00005 each (the “”). The Depositary Shares to be purchased hereunder are referred to herein as the “.”

NOW THEREFORE, in consideration
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and the Investor, intending to be legally bound, hereby agree as follows:

1. CERTAIN DEFINITIONS.

For purposes of this Agreement,
the following terms shall have the following meanings:

(a) “” means, with respect to an Additional VWAP Purchase made pursuant to hereof, the Business
Day (i) that is the VWAP Purchase Date with respect to the corresponding VWAP Purchase referred to in clause (i) of the proviso in the
second sentence of hereof and (ii) on which the Investor receives, after 2:00 p.m., Eastern time, but prior to 4:00
p.m., Eastern time, on such Business Day, a valid Additional VWAP Purchase Notice for such Additional VWAP Purchase in accordance with
this Agreement.

(b) “” means, with respect to an Additional VWAP Purchase made pursuant to
hereof, eighty-five percent (85%) of the Closing Sale Price of the Depositary Shares on the Business Day immediately preceding the applicable
Additional VWAP Purchase Date with respect to such Additional VWAP Purchase.

(c) “” means, with respect to an Additional VWAP Purchase made pursuant to hereof, an irrevocable
written notice from the Company to the Investor directing the Investor to purchase the number of Purchase Shares specified by the Company
therein as the Additional VWAP Purchase Share Amount to be purchased by the Investor (such specified Additional VWAP Purchase Share Amount
subject to adjustment in accordance with hereof as necessary to give effect to the Purchase Share amount limitations
applicable to such Additional VWAP Purchase Share Amount as set forth in this Agreement) at the applicable Additional VWAP Purchase Price
on the applicable Additional VWAP Purchase Date for such Additional VWAP Purchase.

(d) “” means, with respect to an Additional VWAP Purchase made pursuant to hereof, the lesser
of ninety-five percent (95%) of (i) the Closing Sale Price of the Depositary Shares on the Business Day immediately preceding such Additional
VWAP Purchase Date (to be